Global Direct-To-Consumer Disease Risk And Health Test Market Size, Status And Forecast 2019-2025
- Id : RNR-264586
- Category : Pharma Healthcare
- Publish Date : Mar-2019
- Publisher : Research-N-Reports
- Pages : 123
- Format : PDF
The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder. In 2018, the global Direct-to-consumer Disease Risk and Health Test market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Direct-to-consumer Disease Risk and Health Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Direct-to-consumer Disease Risk and Health Test development in United States, Europe and China. The key players covered in this study 23andMe MyHeritage LabCorp Myriad Genetics Ancestry.com Quest Diagnostics Gene By Gene DNA Diagnostics Center Invitae IntelliGenetics Ambry Genetics Living DNA EasyDNA Pathway Genomics Centrillion Technology Xcode Color Genomics Anglia DNA Services African Ancestry Canadian DNA Services DNA Family Check Alpha Biolaboratories Test Me DNA 23 Mofang Genetic Health DNA Services of America Shuwen Health Sciences Mapmygenome Full Genomes Market segment by Type, the product can be split into Celiac Disease Parkinson Disease Alzheimer Disease Other Market segment by Application, split into Online Offline Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Direct-to-consumer Disease Risk and Health Test status, future forecast, growth opportunity, key market and key players. To present the Direct-to-consumer Disease Risk and Health Test development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Direct-to-consumer Disease Risk and Health Test are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.